CLINICAL Genomics is urging Australians aged 50+ to complete a bowel cancer screening test, with Jun being Cancer Awareness Month.
Bowel cancer is Australia's second largest cancer killer, taking 4,000 lives annually despite being highly treatable if diagnosed early.
Clinical Genomics developed and recently launched Colvera in the USA, a sensitive and specific blood-based circulating tumour DNA test for colorectal cancer recurrence monitoring, which is anticipated to be available in Australia next year.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jun 17
